Taizhou HoudeAoke Biomedical Co., Ltd.
4 clinical trials · Sponsor
◉ Watch Taizhou HoudeAoke Biomedical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Study of LP002 for the Treatment of Patients With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (NCT04600947) | Taizhou HoudeAoke Biomedical Co., Ltd. | 2020-12-30 |
| Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer (NCT04740021) | Taizhou HoudeAoke Biomedical Co., Ltd. | 2020-12-02 |
| A Study of HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma (NCT04756934) | Taizhou HoudeAoke Biomedical Co., Ltd. | 2020-08-20 |
| A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms (NCT04755543) | Taizhou HoudeAoke Biomedical Co., Ltd. | 2019-06-17 |
Track Taizhou HoudeAoke Biomedical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.